ClassID:

94741

C07D275/06 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom

Recent Application in this class:
#1
20260098021
2026-04-09

Nitrosation Reagents and Methods

#2
20250304540
2025-10-02

2-METHYL-2-THIAZOLINE SALT

#3
20250282740
2025-09-11

COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO

#4
20250188046
2025-06-12

ULTRAFAST FLOW SYNTHESIS OF FUNCTIONALIZED SULFONYL FLUORIDES AND SUBSEQUENT SUFEX CONNECTIONS VIA LITHIATED CHEMISTRY

#5
20250122194
2025-04-17

NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS

#6
20250074659
2025-03-06

BAG WITH HIGH WATER VAPOR PROTECTION

#7
20240336556
2024-10-10

R-KETAMINE SALTS AND METHODS OF USE THEREOF

#8
20240327384
2024-10-03

SALTS AND SOLID STATE FORMS OF A KIF18A INHIBITOR COMPOUND

#9
20240294480
2024-09-05

COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO

#10
20240287058
2024-08-29

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

#11
20240027904
2024-01-25

PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS

#12
20230242495
2023-08-03

Nitrosation Reagents and Methods

#13
20230134822
2023-05-04

AMINE COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS

#14
20230113085
2023-04-13

Small molecule inhibitors of TEAD transcription factors

#15
20230024859
2023-01-26

Compounds and compositions for treating conditions associated with NLRP activity

#16
20220378801
2022-12-01

NOVEL COMPOUNDS

#17
20220185785
2022-06-16

INHIBITORS OF CD40-CD154 BINDING

#18
20220151233
2022-05-19

Aqueous 1,2-benzisothiazoline-3-one dispersions

#19
20220064131
2022-03-03

Ammonium salt having saccharin anion

#20
20220009895
2022-01-13

N-NITROSACCHARINS

#21
20220009875
2022-01-13

Nitration

#22
20210347768
2021-11-11

Bicyclic compounds useful as GPR120 modulators

#23
20210347746
2021-11-11

Process for preparing 1,1,3-trioxo-1,2-benzothiazole-6-carboxamide

#24
20210309620
2021-10-07

Substituted imidazoles for preventing and/or treating cell or tissue necrosis

#25
20210278763
2021-09-09

Resist composition and pattern forming process

#26
20210163442
2021-06-03

Crystalline forms of lenalidomide

#27
20210100785
2021-04-08

Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof

#28
20200347027
2020-11-05

Crystalline forms of lenalidomide

#29
20200339525
2020-10-29

Methods and compositions for inhibition of STAT3

#30
20200277256
2020-09-03

Selective ship inhibitors for treating disease

#31
20200231592
2020-07-23

SUBSTITUTED 2-(4-HETEROCYCLYLBENZYL)ISOINDOLIN-1-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1

#32
20200157067
2020-05-21

Process for preparing 1,1,3-trioxo-1,2-benzothiazole-6-carboxamide

#33
20200148635
2020-05-14

FORMIMIDAMIDINE COMPOUNDS USEFUL AGAINST PHYTOPATHOGENIC MICROORGANISMS

#34
20200115353
2020-04-16

NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA

#35
20200089112
2020-03-19

Resist composition and patterning process

#36
20200058959
2020-02-20

Electrolyte for secondary battery, secondary battery, battery pack, electric vehicle, electric power storage system, electric tool and electronic device

#37
20190321349
2019-10-24

Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof

#38
20190218208
2019-07-18

Bicyclic compounds useful as GPR120 modulators

#39
20190169130
2019-06-06

MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT

#40
20190002419
2019-01-03

Process for preparing 1,1,3-trioxo-1,2-benzothiazole-6-carboxamide

#41
20180362543
2018-12-20

HIV REPLICATION INHIBITOR

#42
20180358655
2018-12-13

ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE

#43
20180325870
2018-11-15

Compounds as opioid receptor modulators

#44
20180312530
2018-11-01

PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES

#45
20180312477
2018-11-01

Substituted thiazoles for preventing and/or treating cell or tissue necrosis

#46
20180297966
2018-10-18

COMPOUNDS, COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME

#47
20180297964
2018-10-18

Compounds as inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesothelioma

#48
20180282310
2018-10-04

FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE

#49
20180282291
2018-10-04

Identification of ebsulfur analogues with broad-spectrum antifungal activity

#50
20180230112
2018-08-16

Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols

#51
20180200245
2018-07-19

Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof

#52
20180179205
2018-06-28

Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1

#53
20180118751
2018-05-03

Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators

#54
20180118662
2018-05-03

Tranilast compositions and cocrystals

#55
20180099982
2018-04-12

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

#56
20170362182
2017-12-21

MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT

#57
20170158618
2017-06-08

Tranilast compositions and cocrystals

#58
20170129851
2017-05-11

Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases

#59
20170001998
2017-01-05

Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists

#60
20170000801
2017-01-05

Triarylmethane analogs and their use in treating cancers

#61
20160272598
2016-09-22

Process for the preparation of -iodoamides

#62
20160271175
2016-09-22

Metal complexes and methods of treatment

#63
20160259242
2016-09-08

Onium salt compound, resist composition, and pattern forming process

#64
20160168143
2016-06-16

Salts of Dasatinib in crystalline form

#65
20160168142
2016-06-16

Salts of dasatinib in amorphous form

#66
20160166566
2016-06-16

Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities

#67
20160039785
2016-02-11

Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof

#68
20160030393
2016-02-04

Compounds as opioid receptor modulators

#69
20160009698
2016-01-14

Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities

#70
20150361099
2015-12-17

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

#71
20150361093
2015-12-17

HIV REPLICATION INHIBITOR

#72
20150361025
2015-12-17

Enantioselective process for the preparation of enantiomers of sex pheromones

#73
20150267232
2015-09-24

IN VIVO AND IN VITRO CARBENE INSERTION AND NITRENE TRANSFER REACTIONS CATALYZED BY HEME ENZYMES

#74
20150239829
2015-08-27

Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases

#75
20150232434
2015-08-20

STAT3 inhibitors and their anticancer use

#76
20150210635
2015-07-30

Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient

#77
20150126524
2015-05-07

Salts

#78
20150119428
2015-04-30

Tranilast compositions and cocrystals

#79
20150065471
2015-03-05

SALTS OF 5-[(1R)-2-(AMINO)-1-HYDROXYETHYL]-8-HYDROXYQUINOLIN-2(1H)-ONE

#80
20150051256
2015-02-19

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

#81
20150037733
2015-02-05

Acrylic acid ester derivative and method for producing same, intermediate and method for producing same, high-molecular-weight compound, and photoresist composition

#82
20150031685
2015-01-29

Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists

#83
20140288084
2014-09-25

Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1

#84
20140256779
2014-09-11

Compounds as opioid receptor modulators

#85
20140162989
2014-06-12

Multiple-component solid phases containing at least one active pharmaceutical ingredient

#86
20140031395
2014-01-30

Positive allosteric modulators of the α7 nicotinic acetylcholine receptor and uses thereof

#87
20130303525
2013-11-14

Kappa opioid receptor agonists

#88
20130252953
2013-09-26

Targeting human thymidylate kinase induces DNA repair toxicity in malignant tumor cells

#89
20130090478
2013-04-11

Compounds as opioid receptor modulators

#90
20130046000
2013-02-21

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

#91
20120322810
2012-12-20

NEW SALTS

#92
20120213758
2012-08-23

BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#93
20120190847
2012-07-26

Triarylmethane analogs and their use in treating cancers

#94
20120183522
2012-07-19

Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

#95
20120122883
2012-05-17

NEW SALTS

#96
20120094983
2012-04-19

Acyclic Iinhibitors

#97
20120083603
2012-04-05

High stability polyionic liquid salts

#98
20120077856
2012-03-29

PHARMACEUTICAL PRODUCT

#99
20120059066
2012-03-08

Pharmaceutical salts

#100
20120022117
2012-01-26

Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol

#101
20120015911
2012-01-19

Method and compositions for treating amyloid-related diseases

#102
20120009519
2012-01-12

Compound, resin and photoresist composition

#103
20110319326
2011-12-29

Derivatives of benzothiazines, preparation thereof and application thereof as drugs

#104
20110288066
2011-11-24

Phenoxy acetic acid derivatives

#105
20110237624
2011-09-29

Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents

#106
20110218101
2011-09-08

Chemical compounds

#107
20110124686
2011-05-26

Sultam derivatives

#108
20110071200
2011-03-24

3-amino-benzo [D] isothiazole dioxide derivatives and their use as pesticides

#109
20110071178
2011-03-24

Methods and Compounds for Modulating Cannabinoid Activity

#110
20110039874
2011-02-17

MONOACYLGLYCEROL LIPASE INHIBITORS FOR MODULATION OF CANNABINOID ACTIVITY

#111
20110039819
2011-02-17

SUBSTITUTED PHENOXYBENZAMIDES

#112
20110034472
2011-02-10

Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function

#113
20110034450
2011-02-10

Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof

#114
20100330032
2010-12-30

Heterocyclic antiviral compounds

#115
20100324051
2010-12-23

Compounds as opioid receptor modulators

#116
20100311741
2010-12-09

Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents

#117
20100298364
2010-11-25

Salts 756

#118
20100189762
2010-07-29

TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS

#119
20100173377
2010-07-08

N-sulfonylaminocarbonyl containing compounds

#120
20100167922
2010-07-01

3-amino-1,2-benzisothiazole compounds for combating animal pest

#121
20100160296
2010-06-24

Use of imipramine blue and analogs thereof in treating cancers

#122
20100087442
2010-04-08

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

#123
20100063277
2010-03-11

Intramolecular C-H amination with sulfonyl azides

#124
20100009848
2010-01-14

3-amino-1,2-benzisothiazole compounds for combating animal pest II

#125
20090324569
2009-12-31

BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS

#126
20090312377
2009-12-17

DERIVATIVES OF BENZO[D]ISOTHIAZOLES AS HISTONES DEACETYLASE INHIBITORS

#127
20090306016
2009-12-10

Fatty acid amide hydrolase inhibitors

#128
20090258948
2009-10-15

PHARMACEUTICAL SALTS

#129
20090247594
2009-10-01

Therapeutic compounds

#130
20090209676
2009-08-20

Crosslinked polymers with amine binding groups

#131
20090176745
2009-07-09

TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS

#132
20090137646
2009-05-28

1,2 Benzoisothiazole derivative, and agricultural or horticultural plant disease- controlling agent

#133
20090136473
2009-05-28

BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#134
20090118542
2009-05-07

Process for Production of Optically Active Carboxlic Acid Compound

#135
20090093489
2009-04-09

NOVEL COMPOUNDS FOR TREATMENT OF CANCER AND DISORDERS ASSOCIATED WITH ANGIOGENESIS FUNCTION

#136
20090085006
2009-04-02

Activators for oligonucleotide synthesis

#137
20090069317
2009-03-12

Insecticidal Methods Using 3-Amino-1,2-Benzisothiazole Derivatives

#138
20090062355
2009-03-05

Pharmaceutical Product

#139
20090036420
2009-02-05

BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS

#140
20090023779
2009-01-22

Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents

#141
20080319211
2008-12-25

Process for the preparation of epothilones

#142
20080318976
2008-12-25

Alpha-hydroxy amides as bradykinin antagonists or inverse agonists

#143
20080255169
2008-10-16

Sulphonamide Derivatives

#144
20080249315
2008-10-09

Multifunctional amine capture agents

#145
20080210858
2008-09-04

High stability polyionic liquid salts

#146
20080145907
2008-06-19

N-sulfonyldicarboximide containing tethering compounds

#147
20080125466
2008-05-29

Aryl-Substituted Benzo[D]Isothiazol-3-Ylamine Analogues

#148
20080096888
2008-04-24

Compounds as opioid receptor modulators

#149
20080090883
2008-04-17

Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function

#150
20070281369
2007-12-06

Acousto-Mechanical Detection Systems and Methods of Use

#151
20070265321
2007-11-15

Therapeutic compounds

#152
20070245810
2007-10-25

Detection Cartridges, Modules, Systems and Methods

#153
20070213316
2007-09-13

N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives

#154
20070190662
2007-08-16

Acoustic sensors and methods

#155
20070161664
2007-07-12

THERAPEUTIC COMPOUNDS

#156
20070099985
2007-05-03

Heteroaromate OSC inhibitors

#157
20070099897
2007-05-03

(2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives

#158
20070082909
2007-04-12

Acyclic Iinhibitors

#159
20070078242
2007-04-05

Crosslinked polymers with amine binding groups

#160
20070045622
2007-03-01

N-sulfonylaminocarbonyl containing compounds

#161
20060287375
2006-12-21

Benzisothiazoline derivative, plant disease control agent for agricultural or horticultural use, and pest control agent for agricultural or horticultural use

#162
20060235034
2006-10-19

Novel compounds for treatment of cancer and disorders associated with angiogenesis function

#163
20060223855
2006-10-05

Methods and compositions for treating amyloid-related diseases

#164
20060167268
2006-07-27

Growth hormone secretagogues

#165
20060160870
2006-07-20

3-phenylpropionic acid derivatives

#166
20060148867
2006-07-06

Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof

#167
20060142587
2006-06-29

Benzoisothiazolone compositions

#168
20060135783
2006-06-22

Multifunctional amine capture agents

#169
20060111303
2006-05-25

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

#170
20060106073
2006-05-18

Process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same

#171
20060079498
2006-04-13

Therapeutic compounds

#172
20060069037
2006-03-30

Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors

#173
20060058315
2006-03-16

2-Oxo-ethanesulfonamide derivates

#174
20060041114
2006-02-23

Activators for oligonucleotide synthesis

#175
20060020002
2006-01-26

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

#176
20050267200
2005-12-01

Heteroaromate OSC inhibitors

#177
20050256310
2005-11-17

Therapeutic compounds

#178
20050234065
2005-10-20

Dipeptidyl peptidase-IV inhibitors

#179
20050227076
2005-10-13

N-sulfonyldicarboximide containing tethering compounds

#180
20050203143
2005-09-15

Compounds as opioid receptor modulators

#181
20050194561
2005-09-08

Anionic-sweetener-based ionic liquids and methods of use thereof

#182
20050187273
2005-08-25

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

#183
20050176790
2005-08-11

Pharmaceutical salts

#184
20050165073
2005-07-28

Isothiazolone composition and method for stabilizing isothiazolone

#185
20050112672
2005-05-26

N-sulfonylaminocarbonyl containing compounds

#186
20050107615
2005-05-19

N-sulfonylaminocarbonyl containing compounds